Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes

Le Roux, CW, Lau, DCW, Fujioka, K, Greenway, F, Wilding, JPH ORCID: 0000-0003-2839-8404, Jacobsen, PB, Skjoth, T and Madsbad, S (2017) Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes. .

$[thumbnail of M:\Word\Clinical Trials\NOVO\SCALE OBESITY\Le Roux DUK abstract 2017 Early weight loss responders to liraglutide 3.docx]$

Text
M:\Word\Clinical Trials\NOVO\SCALE OBESITY\Le Roux DUK abstract 2017 Early weight loss responders to liraglutide 3.docx - Author Accepted Manuscript
Download (13kB)

Item Type:	Conference or Workshop Item (Unspecified)
Depositing User:	Symplectic Admin
Date Deposited:	15 Nov 2017 16:16
Last Modified:	19 Jan 2023 06:51
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3010966